Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pain × Ralfinamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 1 Neuroma 1

Interventions

Fentanyl 24 Analgesia 21 Morphine 17 Acupuncture Therapy 17 Surveys and Questionnaires 15 Zoledronic Acid 13 Therapeutics 13 Oxycodone 13 Acetaminophen 13 Psychiatric Rehabilitation 12 Ketamine 12 Radiotherapy 11 Lidocaine 11 Hydromorphone 11 Methadone 10 Ibandronic Acid 10 nabiximols 9 Ropivacaine 9 Bupivacaine 9 Analgesics, Opioid 7 Early Intervention, Educational 6 Water 5 Tapentadol 5 Pregabalin 5 Music Therapy 5 Methods 5 Docetaxel 5 Cryotherapy 5 Cryosurgery 5 Control Groups 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01019824 2017-09-15

Efficacy and Safety of Ralfinamide in Patients With Chronic Neuropathic Low Back Pain

Newron Pharmaceuticals SPA

Phase 3 Completed

Neuroma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡